Pfizer Inc.
PFEA primary-source company identity page built for fast discovery, filing verification and consistent financial research.
A recent price could not be verified. Check the exchange before trading.
Four checks before any decision
Business model
Understand how the company earns and where demand originates.
Revenue and margin
Compare equivalent periods; separate growth from profitability.
Debt and cash flow
Test balance-sheet resilience and cash conversion.
Valuation and risk
Use sector peers, scenarios and explicit risk limits.
Company calendar
Pfizer third-quarter 2026 results
Pfizer will issue its third-quarter 2026 Performance Report on the morning of November 3. The company did not specify a more precise report time; the analyst call begins that day at 10:00 AM EST / 6:00 PM Istanbul.
Pfizer ↗Pfizer third-quarter analyst call
Pfizer management will discuss the third-quarter Performance Report due on the morning of November 3 at 10:00 AM EST / 6:00 PM Istanbul that day.
Pfizer ↗Pfizer fourth-quarter 2026 dividend record date
November 6 is the record date for Pfizer's gross cash dividend of $0.43 per common share for the fourth quarter of 2026. The company did not announce a separate ex-dividend date.
Pfizer ↗Pfizer fourth-quarter 2026 dividend payment
Pfizer will pay a gross cash dividend of $0.43 per common share on December 7 to holders of record at the close of business on November 6. The net amount depends on the investor's tax status and intermediary deductions.
Pfizer ↗More NYSE records
Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.
Checking SEC financial statements
A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.